Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081056 | SCV000112963 | uncertain significance | not provided | 2013-04-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002514428 | SCV003497872 | benign | Rubinstein-Taybi syndrome | 2024-08-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004782050 | SCV005395335 | likely benign | not specified | 2024-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003894939 | SCV004711419 | likely benign | CREBBP-related disorder | 2021-12-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |